On the counter, in a study on 115 patients, the blood sample tests demonstrated that serum IL-2 was lower in patients with severe or moderate COVID-19 than individuals with asymptomatic and mild COVID-19 [95]. The gene discussed is IL2; the disease is COVID-19.